SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mac S. Giballa who wrote (3180)12/10/1997 10:24:00 AM
From: Musa Goksel Bulat  Read Replies (2) of 23519
 
VVUS missed the last quarter by a penny, Viagra news were not new news. Muse has been in the market and it is successful. They just got approval in U.K. and got upgrades with price targets of $50-$90 for next year or so. Company continuesly says their only problem is capacity problem, they sell whatever they make. 25% drop in revenues is still confusing me, as long as there is not something bad behind this reduction it IS LIKE THEY ARE GIVING AWAY VVUS TODAY FREE. If they earn nothing next quarter their p/e will be 16. If they make 20 cents next quarter p/e will be around 13.

Since VVUS got approval from UK it has been acting weird, some people know about this announcement (which I believe is not negative at all).
If stocks are priced according to their future earnings potential the omly factor which may take this stock is Viagra, and this action has nothing to do with Viagra. Company is not saying that there is any demand slowdown.

May be there is a fundamental change in the way wall street prices stocks that no one here knows about???.

Anyway I belive it is a great buy right know and I also believe it was great buy yesturdat too.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext